Atlas Trials

LEISH-F3 + GLA-SE and the LEISH-F3 + MPL-SE Vaccine

Clinical trial NCT01751048 · COMPLETED

Trial details

NCT number
NCT01751048
Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Leishmaniasis
Start date
2013-03-01
Primary completion
2015-01-01
Enrollment
48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.